Direct and indirect effects of central and general adiposity on cardiovascular diseases: The Tehran Lipid and Glucose Study

Abstract

Aim

The mechanisms linking body mass index to cardiovascular disease are still not clearly defined. The purpose of this study was to find out how much of the effect of central and general adiposity on cardiovascular disease is mediated through blood pressure, cholesterol, and glucose, and how much is independent of these factors.

Methods and results

The study population included participants, aged ≥30 years, free of cardiovascular disease at baseline with median follow-up of 13.9 years. The total effects were broken down into natural direct and indirect effects using the inverse odds weighting method in the context of survival models. Systolic blood pressure, total serum cholesterol, and fasting plasma glucose as the primary measure of blood glucose were used as mediators. Blood pressure and cholesterol with indirect hazard ratios of 1.09 (95% confidence interval: 1.006–1.18) and 1.35 (95% confidence interval: 1.12–1.62) were the most important mediators for overweight-cardiovascular disease and obesity-cardiovascular disease relationships, respectively. The proportion mediated of overweight was 22% (6–47%) for blood pressure, 18% (5–37%) for blood glucose, and 20% (7–43%) for cholesterol. The same measure for obesity was 65% (35–91%) for cholesterol. For central adiposity, blood pressure, glucose, and cholesterol were the most important mediators with proportion mediated of 36% (17–72%), 23% (9–48%), and 21% (8–45%), respectively.

Conclusions

The findings of this study show that proper control of cardiometabolic risk factors of blood pressure, blood glucose, and dyslipidemia in an adult population can be effective to significantly reduce the effects of general and abdominal adiposity on cardiovascular diseases.

Keywords

Cardiovascular disease mediator effects inverse odds weighting direct and indirect effects

Get full access to this article

View all access options for this article.

References

Collaboration Emerging Risk Factors Collaboration. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies. Lancet 2011; 377: 1085–1095.

Van Gaal

Mertens

De Block

. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875–880.

Kahn

Hull

Utzschneider

. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840–846.

Moreno

Pigeot

Ahrens

. Epidemiology of obesity in children and adolescents: Prevalence and Etiology 2011; Vol 2, Springer Science & Business Media.

VanderWeele

. A three-way decomposition of a total effect into direct, indirect, and interactive effects. Epidemiology 2013; 24: 224–232.

Ten Have

Joffe

. A review of causal estimation of effects in mediation analyses. Stat Methods Med Res 2012; 21: 77–107.

Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed 2002; 47: 408–426.

Azizi

Ghanbarian

Momenan

et al.

Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009; 10: 5.

Hadaegh

Harati

Ghanbarian

et al.

Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil 2006; 13: 571–577.

10.

Azizi

Khalili

Aghajani

et al.

Appropriate waist circumference cut-off points among Iranian adults: The first report of the Iranian National Committee of Obesity. Arch Iran Med 2010; 13: 243–244.

11.

Hajifathalian

Rimm

et al.

Mediators of the effect of body mass index on coronary heart disease: Decomposing direct and indirect effects. Epidemiology 2015; 26: 153–162.

12.

Lu Y, Hajifathalian K, Ezzati M, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: A pooled analysis of 97 prospective cohorts with 1· 8 million participants. Lancet 2014; 383: 970–983.

13.

Pearl J. Direct and indirect effects. In: Proceedings of the 17th Conference in Uncertainty in Artificial Intelligence, 2001, (pp. 411–420). San Francisco: Morgan Kaufmann Publishers Inc.

14.

Robins

Greenland

. Identifiability and exchangeability for direct and indirect effects. Epidemiology 1992; 3: 143–155.

15.

VanderWeele

Vansteelandt

. Conceptual issues concerning mediation, interventions and composition. Stat Interface 2009; 2: 457–468.

16.

Tchetgen Tchetgen

. Inverse odds ratio-weighted estimation for causal mediation analysis. Stat Med 2013; 32: 4567–4580.

17.

Nguyen

Osypuk

Schmidt

et al.

Practical guidance for conducting mediation analysis with multiple mediators using inverse odds ratio weighting. Am J Epidemiol 2015; 181: 349–356.

18.

Royston

Sauerbrei

. Multivariable model-building: A pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables, John Wiley and Sons, 2008.

19.

Mansournia

Altman

. Inverse probability weighting. BMJ 2016; 352: i189.

20.

Mansournia

Etminan

Danaei

et al.

Handling time varying confounding in observational research. BMJ 2017; 359: j4587.

21.

Mansournia

Danaei

Forouzanfar

et al.

Effect of physical activity on functional performance and knee pain in patients with osteoarthritis: Analysis with marginal structural models. Epidemiology 2012; 23: 631–640.

22.

VanderWeele

. Unmeasured confounding and hazard scales: Sensitivity analysis for total, direct, and indirect effects. Eur J Epidemiol 2013; 28: 113–117.

23.

Keavney

McKenzie

Parish

et al.

Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet 2000; 355: 434–442.

24.

Liu

Willett

Stampfer

et al.

A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 2000; 71: 1455–1461.

25.

Kelishadi

Hashemi Pour

Sarraf-Zadegan

et al.

Obesity and associated modifiable environmental factors in Iranian adolescents: Isfahan Healthy Heart Program − heart health promotion from childhood. Pediatr Int 2003; 45: 435–442.

26.

Resche-Rigon

White

. Multiple imputation by chained equations for systematically and sporadically missing multilevel data. Stat Methods Med Res 2016; 27: 1634–1649.

27.

Kazempour-Ardebili

Ramezankhani

Eslami

et al.

Metabolic mediators of the impact of general and central adiposity measures on cardiovascular disease and mortality risks in older adults: Tehran Lipid and Glucose Study. Geriatr Gerontol Int 2017; 17: 2017–2024.

28.

Jahangiri-Noudeh

Akbarpour

Lotfaliany

et al.

Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: A Middle Eastern cohort study. PloS One 2014; 9: e112639.

29.

Finucane

Stevens

Cowan

et al.

National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377: 557–567.

30.

MacKinnon

Fairchild

Fritz

. Mediation analysis. Annu Rev Psychol 2007; 58: 593–614.

31.

Edwards

Lambert

. Methods for integrating moderation and mediation: A general analytical framework using moderated path analysis. Psychol Methods 2007; 12: 1–22.

32.

VanderWeele

. Explanation in causal inference: Methods for mediation and interaction, USA: Oxford University Press, 2015.

33.

Goh

Dhaliwal

Welborn

et al.

Anthropometric measurements of general and central obesity and the prediction of cardiovascular disease risk in women: A cross-sectional study. BMJ Open 2014; 4: e004138.

34.

Coutinho

Goel

De Sá

et al.

Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: Role of “normal weight central obesity”. J Am Coll Cardiol 2013; 61: 553–560.

35.

Haapala

Lankhorst

de Groot

et al.

The associations of cardiorespiratory fitness, adiposity and sports participation with arterial stiffness in youth with chronic diseases or physical disabilities. Eur J Prev Cardiol 2017; 24: 1102–1111.

36.

Van Gaal

Mertens

Christophe

. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875–880.

37.

Poirier

Giles

Bray

et al.

Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association scientific statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898–918.

38.

de Almeida-Pititto

Ribeiro-Filho

Santos

et al.

Association between carotid intima-media thickness and adiponectin in participants without diabetes or cardiovascular disease of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Eur J Prev Cardiol 2017; 24: 116–122.

39.

Collaboration Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 2010; 375: 132–140.

40.

Aleksandrova

Mozaffarian

Pischon

. Addressing the perfect storm: Biomarkers in obesity and pathophysiology of cardiometabolic risk. Clin Chem 2018; 64: 142–153.

41.

VanderWeele

. Mediation analysis with multiple versions of the mediator. Epidemiology 2012; 23: 454–463.

42.

MacKinnon

. Introduction to statistical mediation analysis, New York: Taylor & Francis Group/Lawrence Erlbaum Associates, 2008.

43.

Messerli

Grossman

. Diabetes, hypertension, and cardiovascular disease: An update. Hypertension 2001; 38: e11.

44.

Beckman

Creager

Libby

. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570–2581.

45.

Franz

VanWormer

Crain

et al.

Weight-loss outcomes: A systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007; 107: 1755–1767.

46.

Gray

Cooper

Dunkley

et al.

A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity. Obes Rev 2012; 13: 483–498.

47.

Sjöström

Narbro

Sjöström

et al.

Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741–752.

48.

Anand

Yusuf

. Stemming the global tsunami of cardiovascular disease. Lancet 2011; 377: 529–532.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.48 MB